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The change in cytoplasmic free calcinm, [Ca’+]i in isolated bovine adrenal medullary cells during stimulation 
by acetylcholine (ACh) in Ca2+-free incubation medium was measured using the fluorescent Ca2+ indicator 
qnin2. ACh (l-100 PM) caused an increase in [Ca2+fi by mobilization of Ca2+ from the intracelhtlar pool. 
Nicotine (10 FM) did not increase [Ca2+l, in the absence of extracellular Ca”. Pretreatment of the cells with 
atropine (10 PM) completely inhibited ACh-induced increase in [Ca2+], whereas pretreatment with 
hexamethonium (100 PM) did not. The intracellnlar C!a2+ antagonist 8-(N,&diethylamino)octyl-3,4,5- 
trimethoxybenzoate (TMB-I), inhibited ACh-induced increase in [Ca2+],. The activator of protein kinase 
C 12-O-tetradecanoylphorbol- 13-acetate (TPA), but not its ‘inactive’ analog 4u-phorbol- 12,13_didecanoate 
(PDD), also inhibited ACh-induced increase in [Ca2+l,. These findings suggest hat in bovine adrenal medul- 
Iary cells, stimulation of muscarinic ACh receptor canses an increase in [Ca2+], by mobi~ng Ca2+ from 
the intracellular pool and that protein kinase C is involved in ‘termination’ or ‘down regnlation’ of this 
response. 
Muscarinic receptor Cytoplasmic free Ca2+ TMP-8 
1. INTRODUCTION 
ACh stimulates the release of catecholamine 
from adrenal medullary cells by a process depen- 
dent on extracellular Ca2’ [l]. Studies using 45Ca2+ 
showed that stimulation of nicotinic ACh receptor 
results in increased uptake of 45Ca2+ into the cells 
and subsequent increase in catecholamine release 
from the cells [2-51. Bovine adrenal medullary 
cells have both nicotinic and muscarinic receptors 
on their surface. Stimulation of musc~nic ACh 
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Phorbol ester Protein kinase C Adrenal medulla 
receptor does not cause uptake of 45Ca2+ and 
release of catecholamine [3], but increases PI turn- 
over [a-8], the cyclic GMP level [9, lo] and 4sCa2+ 
efflux from the cells [3,1 i]. However, the role of 
muscarinic receptor in bovine adrenal medullary 
cells is still unknown. 
Recently, it has become possible to measure in- 
tracellular [Ca2’]i in bovine adrenal medullary 
cells both in the resting condition and during 
stimulation by secretagogues [12-141. 
In this study, we examined the roles of nicotinic 
and muscarinic receptors in mobilization of [Ca2’]i 
in the absence of extracellular Ca2+ using the 
fluorescent dye quin2. While the preparation of 
this manuscript was in progress, Kao and 
Schneider reported that stimulation of the 
musc~i~c receptor causes an increase in [Ca2+]i 
which is independent of extracellular Ca2+ [Is]. 
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2. MATERIALS AND METHODS 
Isolated cells were prepared in large quantity by 
sequential digestion of bovine adrenal medullary 
slices with collagenase as described [ 161. Adrenal 
medullary cells at a density of 7 x lo6 per ml were 
incubated with quin2 acetoxymethyl ester (10 FM) 
in Krebs-Ringer phosphate buffer containing Ca*+ 
at 37°C for 1 h. The intracellular quin2 concentra- 
tion was calculated to be approx. 1 mM. The cells 
were then washed with Ca*+-free Ringer solution 
and kept in the same solution for 30 min at 0°C 
before starting experiments. All experiments were 
done at 37°C and fluorescence was measured 
simultaneously with a spectrofluorophotometer 
(excitation 339 nm, emission 492 nm). Cells were 
pre-incubated at 37°C for 5 min with or without 
cholinergic antagonists, TMB-8, TPA or PDD 
before challenge with ACh or nicotine. When 
necessary, EGTA (adjusted to the required pH) 
was added 2 min before stimulation. Fluorescence 
measurements were interrupted for addition of a 
stimulator and/or gentle up and down mixing of 
the cell suspension by Pasteur pipette. After each 
experiment, digitonin at 50pg/ml was added to 
lyse the cells and [Ca*+]i concentration was 
calculated from the intracellular trapped quin2 as 
described in [17]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows the changes in fluorescence of 
quin2-loaded cells after exposure to different con- 
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Fig. 1. Effect of various concentrations of ACh (a-d) on 
the [Ca’+]i level in quinZloaded isolated bovine adrenal 
medullary cells in the presence of extracellular Ca2+ at 
2.2 mM. The arrow indicates the time of addition of 
ACh to the cuvette containing 2 ml of cell suspension 
(7 x lo6 cells/ml) and then mixing by gentle up and 
down movement of the cell suspension. Cell fluorescence 
was recorded before and after the addition of ACh. 
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centrations of ACh in the presence of extracellular 
Ca2+ at 2.2 mM. [Ca*+]i was increased dose- 
dependently by ACh and was maximal with 
100,uM ACh. The concentrations of [Ca*+]i both 
in the resting condition and after stimulation by 
ACh were similar to those in [12,14]. 
Fig.2 shows the increases in [Ca*+]i n adrenal 
medullary cells incubated without Ca*+ with dif- 
ferent concentrations of ACh. When the cells were 
incubated in the absence of extracellular Ca*+, the 
resting [Ca*+]i decreased. Subsequent stimulation 
with ACh resulted in slight increase in [Ca*+]i. 
Nicotine (10 /IM) also caused slight increase in 
[Ca*+]i. This increase in [Ca*+]i n the presence of 
nicotine may be due to nicotinic receptor-mediated 
uptake of Ca*+ by the cells, because the incubation 
medium contained a micromolar concentration of 
Ca*+. To clarify this point, we stimulated 
quin2-loaded adrenal medullary cells after removal 
of extracellular Ca*+ by addition of 2 mM EGTA 
(fig.3). In this medium, nicotine did not change the 
[Ca*+]i level, whereas ACh caused increase in 
[Ca*+]i, possibly by release of Ca*+ from the in- 
Fig.2. Changes in [Ca”]r caused by ACh (a-d) and 
nicotine (e) in medium without added Ca2+ (containing 
a micromolar concentration of contaminating Ca’+). 
Cells were pre-incubated at 37°C for 5 min and then 
ACh or nicotine was added at the time indicated by an 
arrow. 
Fig.3. Effect of cholinergic agonist on the [Ca’+]i level 
in Ca2’ free medium in the absence or presence of 
antagonist. Cells were pre-incubated for 5 min in the 
absence (a-d) or presence of an antagonist, such as 
hexamethonium 1OOpM (e) or atropine 1OpM (f). 
EGTA was added at 2 mM to all cell suspensions 2 min 
before the addition of ACh or nicotine. 
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tracellular pool. Atropine (lO/cM), a muscarinic 
antagonist, inhibited ACh-induced increase in 
[Ca”]i whereas hexamethonium (100 FM), a 
nicotinic antagonist, did not affect ACh-induced 
increase in [Ca’+]i. These results indicate that the 
ACh-induced increase in [Ca2’]i is caused mainly 
by uptake of Ca2+ into the cells by nicotinic recep- 
tor stimulation and partly by release of Ca2+ from 
the intracellular Ca2+ pool by muscarinic receptor 
stimulation. The increase in [Ca’+]i mediated by 
muscarinic receptor does not seem sufficient for 
initiation of catecholamine secretion 1151. 
The effect of the intracellular Ca*+ antagonist 
TMB-8 [IS] on muscarinic receptor-mediated in- 
crease in fCa2+]i was examined. As shown in fig.4, 
TMB-8 (100 FM) inhibited ACh-induced increase 
in [Ca2”]i in the absence of extracellular Ca*+, in- 
dicating that TMB-8 inhibits Cat’ release from the 
intracellular pool mediated by muscarinic receptor 
stimulation. This result seems consistent with the 
report that TMB-8 inhibited carbamylcholine- 
stimulated 45Ca2+ efflux from 4SCa’+-preloaded 
cultured cells [ 191. 
Next we examined whether protein kinase C 
regulates Cazf mobilization using phorbol ester to 
activate protein kinase C [20]. Results showed that 
the muscarinic receptor-mediated increase in 
fCa’+]i was inhibited by TPA, but not by PDD, a 
phorbol ester analog that does not activate protein 
kinase C [20]. TPA was inhibitory at concentra- 
tions of above 1 nM and caused complete inhibi- 
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Fig.4. Effect of TMB-8, TPA and PDD on ACh-induced 
change in [Ca’+]i level. Cell suspensions were pre- 
incubated for 5 min in Ca’+-free medium in the absence 
(a,d) or presence of 1 PM TMB-8 (b), 100~M TMB-8 
(c), 1 nM TPA (e), 10 nM TPA (f), 100 nM TPA (g) or 
100 nM PDD (h). EGTA was added at 2 mM to cell 
suspensions 2 min before addition of ACh (1OOpM) at 
the time indicated by an arrow. 
tion at a concentration of 100 nM (fig.4). These 
findings suggest that the phorbol ester TPA in- 
hibited muscarinic receptor-mediated Ca2’ release 
from the intracellular pool by activating protein 
kinase C. 
The Ca2+-ionophore A23 187 also stimulated the 
release of Ca2’ from the intracellular Ca2+ pool, 
but its effect was not influenced by pre-treatment 
of the cells with TPA (100 nM) (not shown). 
In bovine adrenal medullary cells, stimulation of 
the muscarinic receptor caused increase in not only 
PI turnover [7,8], but also the cyclic GMP level 
[9,10] and 45Ca2+ efflux from the cells [3,11]. The 
possibility that cyclic GMP is involved in 
muscari~c receptor-mediated release of Ca2’ from 
internal stores can be excluded by the fact that in- 
crease in the cyclic GMP level by ACh is dependent 
on extracellular Ca2+ [lo]. Moreover, the in- 
hibitory effect of TPA on muscarinic receptor- 
mediated increase in [Ca2+]i could not be overcome 
by addition of 1 mM dibutyryl cyclic GMP (not 
shown). The increase in turnover of PI does not re- 
quire the presence of extracellular Ca2+ [21]. It is 
known that increase in PI turnover leads to forma- 
tion of inositol phosphate and diacylglycerol 
f22-241. Inositol 1,4,5-t~phosphate may be in- 
volved in mobilization of Ca” from its in- 
tracellular pool 125-271, and diacylglycerol, like 
TPA, stimulates protein kinase C [20,23,24]. It is 
of particular interest that diacylglycerol, which is 
formed concomitantly with inositol phosphate, in- 
hibits Ca2+ mobilization by activation of protein 
kinase C. 
Recently, a similar inhibitory action of phorbol 
ester on receptor-mediated intracellular Ca2” 
movement has been observed in other tissues, such 
as isolated hepatocytes [28] and neutrophils [29], 
To summarize, these results demonstrate by 
direct measurement that in isolated bovine adrenal 
medullary cells, increase in [Ca2’]i released from 
the intracellular pool is mediated by muscarinic 
stimulation. The phorbol ester TPA inhibited this 
increase in [Ca*+]i, possibly by activating protein 
kinase C, suggesting that protein kinase C may 
have a negative influence on muscarinic receptor- 
mediated Ca2+ release from the intracellular pool. 
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